VITA-GBM: EPIC-0502-Driven HIF1alpha Degradation Overcomes Bevacizumab Resistance and Synergizes with TMZ in Glioblastoma. Ding Y, Zhan Q, Cui L, Cui X, et al. Neuro Oncol 2025 Dec 31:noaf293. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ding Y, Zhan Q, Cui L, Cui X, et al. VITA-GBM: EPIC-0502-Driven HIF1alpha Degradation Overcomes Bevacizumab Resistance and Synergizes with TMZ in Glioblastoma. Neuro Oncol 2025 Dec 31:noaf293. doi: 10.1093.
PMID: 41476110